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Objective evaluation of cerebrovascular reactivity for acetazolamide predicts cerebral 
hyperperfusion after carotid artery stenting: Comparison with region of interest 




BACKGROUND AND PURPOSE: Hemodynamic impairments are considered risk factors 
of cerebral hyperperfusion after carotid artery stenting (CAS); measurement by SPECT using 
a subjective ROI method lacks consistency and reproducibility.  
MATERIALS AND METHODS: The present study compared objective perfusion analysis 
(stereotactic extraction estimation [SEE] method) with the ROI method for preoperative 
SPECT to predict the hyperperfusion phenomenon (HPP) after CAS. Preoperative resting 
asymmetry index (CBF ratio from the affected to unaffected hemisphere) and cerebrovascular 
reactivity (CVR) to acetazolamide were measured by N-isopropyl-p-[123I]-iodoamphetamine 
SPECT using the SEE and ROI method in 84 patients. CBF was also measured the day after 
CAS. Perfusion data with the highest area under the curve (AUC) by receiver-operating 
characteristic (ROC) analysis was considered a perfusion risk factor of HPP. Multivariate 
analyses for clinical characteristics and perfusion risk factors were performed to determine 
predictors of HPP.  
RESULTS: The HPP was observed in 10 patients (11.9%). Female sex, contralateral stenosis, 
and degree of stenosis were significantly associated with HPP development on univariate 
analysis, and symptomatic stenosis was not found to be a significant factor. On SPECT 
analysis, CVR in the MCA area by SEE method had the highest AUC (0.981). Multivariate 
analysis showed that CVR in the MCA area was a significant predictor of HPP (p=0.041). To 
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predict hyperperfusion, the ROC curve of the CVR showed a cutoff value of -0.60%, 
sensitivity of 94.6%, and specificity of 100% (p<0.001). 
CONCLUSIONS: Objective SEE method had better a predictive capability than ROI 
method to identify risk of hyperperfusion after CAS.  
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Carotid artery stenting (CAS) has been performed as an alternative to carotid endarterectomy 
(CEA) for revascularization in cases of carotid artery stenosis in which CEA carries a high 
risk. Although cerebral infarction and in-stent restenosis were reported as common 
complications associated with CAS, cerebral hyperperfusion syndrome (HPS) following CAS 
is a rare but potentially devastating complication that occurs under the conditions of the 
hyperperfusion phenomenon (HPP) [1-12]. The prognosis of HPS has a poor prognosis, with 
mortality rates of 36 to 63%, and survivors have significant morbidity [13]. Consistent with 
reports describing cerebral hyperperfusion after CEA, the reported preoperative risk factors 
of hyperperfusion after CAS are patient age, asymmetry index (ipsilateral/contralateral 
resting cerebral blood flow [CBF]), cerebrovascular reactivity (CVR) to acetazolamide, 
severe internal carotid artery stenosis, contralateral stenosis or occlusion, and periprocedural 
hypertension [14, 4, 3, 1, 15]. Although previous studies assessed CVR and asymmetry index 
using SPECT with the ROI method, the ROI method lacks consistency among studies and has 
poor reproducibility [4, 3, 16]. Conversely, the stereotactic extraction estimation (SEE) 
method can automatically analyze the brain perfusion data in stereotactic space objectively 
and reproducibly [16, 17]. Different from the ROI method, the perfusion data using the SEE 
method were depicted to whole brain surface area, and automatically quantifies the CBF and 
CVR in each pre-defined region of the anterior cerebral artery (ACA), middle cerebral artery 
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(MCA), and posterior cerebral artery (PCA) [17]. No reports have compared the objective 
SEE and ROI method for detection of risk factors of HPP. The present study retrospectively 
evaluated the strongest risk factor of cerebral hyperperfusion after CAS among SPECT data 
with both the SEE and ROI method. 
 
Methods 
The eligibility criterion was stenosis of the internal carotid artery of more than 50% on digital 
subtraction angiography in symptomatic patients, and more than 80% in asymptomatic 
patients. During the study period (January 2007 to December 2015), 106 consecutive patients 
underwent CAS. Of these, 22 patients were excluded from analysis for the following reasons: 
emergent CAS without preoperative SPECT (N=5), previous large old cerebral infarction 
(N=2), staged angioplasty (N=1)[18], subsequent CAS for restenosis after initial CAS (N=1), 
and lack of preoperative SPECT N-isopropyl-p-[123I]-iodoamphetamine (IMP) (N=13). Thus, 
84 patients remained for our analysis (73 men and 11 women). The mean age of the patient 
population was 70.4 ± 7.1 years (range, 52–84 years). The patient characteristics are shown in 
Table 1. 
  This study was reviewed and approved by the institutional ethics committee. Informed 




Single Photon Emission Computed Tomography 
We performed preoperative CBF 123I-IMP SPECT study at rest and with an acetazolamide 
challenge. CBF SPECT at rest was also performed the following day after CAS. The 
preoperative CBF SPECT data were obtained using the dual table autoradiography 
(DT-ARG) method, which was modified from the original autoradiography (ARG) method. 
The DT-ARG method can acquire CBF SPECT images both at rest and with an acetazolamide 
challenge in one day [19, 20, 17]. First, patients were administered 111 MBq of 123I-IMP 
intravenously, while resting CBF SPECT acquisition was started simultaneously. Blood was 
sampled from the brachial artery 10 min after the injection. Second, for the drug challenge, 
15 mg/kg of acetazolamide was injected 20 min after the resting 123I-IMP injection. Finally, 
10 min after the acetazolamide injection, 111 MBq of 123I-IMP was administered to the 
patients and CBF SPECT was acquired for the acetazolamide challenge. The SPECT 
acquisition time was 28 min for each of the resting and the acetazolamide challenge 
conditions, and the total examination time was <1 hour. The postoperative CBF imaging was 
performed using the ARG method, which followed the same protocol as the first step of the 
preoperative SPECT. All images were obtained by an e-cam dual-headed gamma camera 
(Siemens Healthcare GmbH, Erlangen, Germany) equipped with low-energy high-resolution 
fan-beam collimators. Projection data were obtained with a 64 x 64 matrix in 4 min x 7 
rotations of 180 degrees from each camera at a sampling step angle of 4 degrees, and with 
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triple photopeaks for triple energy window (TEW) scatter correction (160 keV, 24% and 134, 
172 keV, 3%). Scanning was performed with a transaxial resolution of 9.6 mm in full-width 
at half-maximum (FWHM). 
  Each projection image was executed with QSPECT, the automated package software 
supplied by Nihon Medi-Physics Co., Ltd. (Tokyo, Japan). The DT-ARG algorithm in the 
software has been described previously; briefly, it is based on the autoradiography method 
using two look-up tables, and it can acquire CBF data under an acetazolamide challenge just 
after performing resting CBF [20]. After scatter correction was performed with the TEW 
method, tomographic images were reconstructed from the 64 x 64 matrix in the transverse 
plane using an ordered subset expectation maximization algorithm with 3 iterations and 5 
subsets. Attenuation correction was performed using the sinogram threshold fitting (estimated 
skull image by filtered back projection of the reciprocal of an emission sinogram) using the 
Chang method (0.167 cm-1). After reconstruction, a 7.0-mm FWHM Gaussian post-filter was 
applied. The reconstructed spatial pixels were 2.85 mm for the x- and y-planes and 3.44 mm 
for the z-plane. Reconstructed images were translated into quantitative tomographic images 
from arterial sampling data using the DT-ARG method for the preoperative study and the 
ARG method for the postoperative study. 
For the SEE method, all imaging data was analyzed using a PC running Windows 7 
(Microsoft, Redmond, WA). Brain surface images were obtained using the three-dimensional 
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stereotactic surface projection (3D-SSP) programs. To ensure the correct transfer to the 
stereotactic brain coordinates, we evaluated the fit of the transferred midsagittal images at 
rest and for the acetazolamide challenge by superimposing the midsagittal images. The SEE 
method can show 3D-SSP format view sets of CBF without acetazolamide (Rest CBF), CBF 
with acetazolamide (acetazolamide CBF), CVR, and staging of hemodynamic ischemia 
(Figure 1A, B). The borderline of ACA, MCA, and PCA territories were preset on the brain 
surface image using 3D-SSP programs (Figure 1B). The SEE method evaluated the mean 
CBF and CVR in the entirety of each territory. CVR and asymmetry index were defined as 
(acetazolamide CBF - Rest CBF)/Rest CBF×100 (%) and the ipsilateral Rest 
CBF/contralateral Rest CBF, which were automatically calculated.  
For the ROI method, slices at the anterior commissure-posterior commissure level +20 mm 
of the standardized images was used [21]. In this slice, six ROIs, the ACA, anterior and 
posterior part of the MCA, anterior and posterior part of the white matter (WM), and PCA, 
were placed (Figure 1C). Rest CBF, acetazolamide CBF, CVR, and asymmetry index at rest 
were measured in each area.  
 
Intraoperative and Postoperative Management 
Carotid artery angioplasty and stenting were performed by three neurointerventionalists. Dual 
(aspirin 100 mg and clopidogrel 75 mg) or triple (aspirin 100 mg, clopidogrel 75 mg, and 
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cilostazol 200 mg) antiplatelet therapy was administered for a minimum of 7 days prior to the 
procedure. The free radical scavenger edaravone (30 mg) (Tanabe Mitsubishi Parma Co, 
Tokyo, Japan) was preoperatively administered in all patients to prevent cerebral 
hyperperfusion [22]. The patients were placed under local anesthesia, and a bolus injection of 
heparin (80 IU/kg) was given immediately before the intervention to increase the activated 
clotting time to a minimum of 250 seconds. A 6 French, 90 cm catheter sheath was inserted 
from the femoral or brachial artery to the ipsilateral common carotid artery. We used 
Angioguard (Johnson & Johnson, Cordis, Minneapolis, MN, USA), FilterWire (Boston 
Scientific, Natick, MA, USA), or GuardWire (Medtronic, Santa Rosa, CA, USA) as the 
embolic protection device for all patients. All but 7 patients underwent predilation of the 
internal carotid lesions using a 3.5-mm balloon catheter protected with the embolic protection 
device. Precise (Johnson & Johnson, Cordis) and Wallstent RP (Boston Scientific) were used 
in 40 and 44 patients, respectively. Postdilation was performed in 70 patients with a 4.5- or 
5.0-mm balloon catheter with 6-atm inflation pressure. In cases with insufficient stent 
expansion, the balloon was further inflated to 10 atm.  
  HPP was defined as an asymmetry index of more than 1.20 compared with the normal side 
on SPECT the day after CAS [18, 23]. HPS was defined as a neurological deficit that 
occurred after cerebral revascularization, was localized ipsilateral to the treated artery, and 





Data are presented as the mean ± standard deviation. Statistical analysis was performed using 
SPSS (version 23.0 for Windows; SPSS Inc, Chicago, IL). We used Fisher’s exact test and the 
χ2 test for categorical variables. The association between HPP and continuous variables was 
estimated by calculating odds ratios (OR) with 95% confidence intervals (CIs), using binary 
logistic regression models. For SPECT data, the factor which had the highest value of the 
area under the curve (AUC) on receiver-operating characteristic (ROC) curve analyses was 
considered as the strongest risk factor of HPP. On multivariate analysis, the models were 




The baseline characteristics of the patients are shown in Table 1. Among 84 patients, 73 
(86.9%) were men and 11 (13.1%) were women, and their mean age was 70.4 ± 7.1 years. 
The overall average degree of ICA stenosis was 74.8 ± 17.6% (range, 52%–95%) according 
to the method of the North American Symptomatic Carotid Endarterectomy Trial [24]. CAS 
was performed without neurological deterioration in all but two patients who suffered minor 
cerebral infarction in the affected MCA area with mild hemiparesis.  
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Ten patients (11.9%) met the CBF criteria for post-CAS HPP on the SPECT imaging 
performed the next day. Of these patients, one developed cerebral HPS with symptoms of 
headache and confusion, which were resolved without neurological deficits by strict control 
of blood pressure (<80 mmHg) under coma therapy. The results of the univariate analysis of 
factors related to the development of cerebral HPP after CAS are summarized in Table 1. 
Female sex, degree of stenosis, and contralateral stenosis were significantly associated with 
the development of post-CAS cerebral hyperperfusion (p<0.05).  
The preoperative cerebral perfusion analyses using SEE method are shown in Table 2. 
CBF at rest was not associated with HPP in the ACA, MCA, and PCA areas. CBF after 
acetazolamide, asymmetry index at rest, and CVR were significantly associated with HPP 
after CAS in the ACA, MCA, and PCA areas (p<0.05).  
The cerebral perfusion analyses using ROI method are shown in Table 3. CBF at rest was 
not associated with HPP in all areas. As with the SEE method, CBF after acetazolamide, 
asymmetry index, and CVR were significantly associated with HPP after CAS in all areas 
(p<0.05).  
The highest value of the AUC (0.981) of CVR was marked in the MCA area by the SEE 
method (Table 2). The CVR of the MCA area in patients with and without HPP was -15.9 ± 
14.0 and 23.5 ± 17.1, respectively (p<0.001). In addition, the highest value of the AUC 
(0.868) of asymmetry index at rest was marked in the posterior part of the MCA area by the 
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ROI method (Table 3). The asymmetry index of this area in patients with and without HPP 
was 0.83 ± 0.08 and 0.97 ± 0.09, respectively (p<0.001). Among all perfusion data measured 
by both the SEE and ROI methods, the CVR in the MCA area by SEE method had the highest 
value of AUC.  
  When the three factors (female sex, contralateral stenosis, and degree of ipsilateral 
stenosis) that showed a significant difference by univariate analyses and CVR of the MCA 
area by SEE method were included as confounders in the logistic regression model for the 
multivariate analysis, only CVR of the MCA area by SEE method (OR, 0.720; CIs, 
0.526-0.987) was significantly associated with the development of postoperative cerebral 
hyperperfusion (p=0.041, Table 4). The ROC curve of the CVR showed a cutoff value of 
-0.60% for the prediction of HPP, with a sensitivity of 0.946 and specificity of 1.000 
(p<0.001, Figure 2).  
 
Discussion 
The present study found that the preoperative mean CVR of the whole MCA area measured 
on SEE analysis, which theoretically produces consistent results across examiners and 
institutions, had a significant predictive value for HPP after CAS. Using a cutoff value of 
-0.60% for CVR, the sensitivity and specificity were 94.6% and 100%, respectively, 
demonstrating that CVR was a good predictive factor. The predictive capability of CVR to 
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acetazolamide was better than the asymmetry index at rest, consistent with a previous study 
on the predictive factors of cerebral hyperperfusion after CEA [14]. The factor, which had the 
highest AUC by asymmetry index at rest, was the posterior part of the MCA by the ROI 
method (0.868 of the AUC). The ROC curve analysis of asymmetry index in posterior part of 
the MCA showed a cutoff value of 0.86 for the prediction of HPP, with a sensitivity of 0.932 
and specificity of 0.800 (p<0.001, data not shown). Although the asymmetry index is a 
relatively good predictor of HPP following CAS, false negatives (developing HPP contrary to 
expectation) exist, which is different from CVR. Complications of endovascular treatment 
may be associated with disastrous consequences, thus false negatives should be avoided [25, 
26]. Because acetazolamide is associated with frequent adverse effects, including metabolic 
acidosis, hypokalemia, numbness of the extremities, headache, tinnitus, gastrointestinal 
disturbances, and Stevens-Johnson syndrome, the asymmetry index at rest, which is evaluated 
without administration of acetazolamide, may be useful to screen for the need for 
acetazolamide administration [27, 28].  
  The pathophysiological mechanism of cerebral HPS remains unclear. Traditionally, HPS is 
attributed to the failure of normal cerebral autoregulation, secondary to long-standing 
changes in perfusion pressure. Maximal dilation of cerebral arterioles for long periods of time 
causes a loss of CBF autoregulation in areas of chronically under-perfused brain tissue and 
can result in hemorrhage and/or edema [6, 4, 14, 8]. In the present study, all patients with 
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HPP had a preoperative CVR <0%, which means that the CBF decreased after acetazolamide 
administration. Although the particular mechanism of this “steal phenomenon” by 
acetazolamide has not been clarified, it is thought to occur in the territory with the maximum 
vasodilatation of the cerebral vascular bed under chronic hemodynamic stress, which could 
explain the association between postoperative cerebral hyperperfusion and the preoperative 
steal phenomenon by acetazolamide [29, 30]. Chronic hypoperfusion due to carotid artery 
stenosis is believed to induce cerebral infarction, and one previous report showed that 
symptomatic patients tend to experience HPP after CEA [14]. To our knowledge, there is no 
report (including the present study) demonstrating a significant relationship between 
symptomatic stenosis and HPP after CAS [3]. 
  The SEE method analyzes the whole MCA territory, and therefore we excluded patients 
who had a relatively large old infarction in the MCA area [15]. CVRs of the ACA and PCA 
are less predictable than that of the MCA for HPP after CAS. CBF in the ACA and PCA 
territories can be highly influenced by collateral flow from the anterior and posterior 
communicating arteries. Additionally, the CVR of the MCA area reflects all factors, including 
main flow from the MCA and collateral flow from the ACA and PCA areas. These 
characteristics of the MCA area are considered to be the reason for higher predictable value 
of HPP than the ACA and PCA areas. Low CVR by the SEE method indicates widespread 
hypoperfusion in the whole range of the MCA area, whereas hypoperfusion by the ROI 
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method reflects hypoperfusion within the localized area, which is considered to explain the 
predictable capability of the SEE method.  
 The development of HPP is reported to occur in 6.8-18.5% of patients after CAS, and the 
11.9% incidence of HPP observed in this study is comparable to the reported incidences [2-4, 
18]. HPS can occur in a proportion of patients with HPP, and the reported incidence of HPS is 
0.7–6.8% after CAS [8, 1, 31, 6, 9]. Although several reports defined HPP as increasing 
ipsilateral CBF over 100% from baseline (200% compared with preoperative baseline)[6, 13, 
32, 33], moderate relative hyperperfusion of the ipsilateral hemisphere was also reported to 
bring about HPS [34]. In the present study, we defined HPP as a resting CBF of >120% in the 
affected hemisphere compared with the unaffected side [18]. The diagnosis of HPP 
development with SPECT in this study was performed the day after CAS, based on the 
evidence that cerebral hyperperfusion after CAS most often occurred within 12 hours of the 
procedure [8, 6, 31, 1]. 
  Contralateral (bilateral) carotid artery stenosis was reported to be a risk factor for cerebral 
hyperperfusion[1], and in the present study, univariate logistic analysis showed that 
contralateral stenosis was a significant risk factor for cerebral HPP following CAS. In the 
present study, the preoperative resting CBF in the contralateral MCA area with and without 
contralateral carotid artery stenosis was 34.2 ± 5.1 and 37.2 ± 7.9 ml/100 g/min, respectively. 
Although there was no significant difference in CBF in the contralateral MCA area (p=0.074), 
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a slightly decreased CBF in the contralateral MCA area provokes impairment of ipsilateral 
cerebral perfusion due to poor collateral flow, which contributes to the development of 
cerebral hyperperfusion following CAS.  
  Regarding demographic factors, 5/10 patients who developed HPP after CAS were female, 
and female sex was a significant predictor of HPP development by univariate analysis in the 
present study. Coutts et al. and Morrish et al. demonstrated that 2/3 and 2/4 patients with 
postoperative HPS after CAS were female,[8, 9] and another report demonstrated that female 
sex was associated with a decreased CVR [35]. Although these reports suggest female 
patients are at a higher risk for cerebral hyperperfusion following CAS, to the best of our 
knowledge, there is no remarkable evidence of a higher risk for female patients for 
developing postoperative cerebral hyperperfusion.  
  The most important perioperative management strategies for the prevention of HPS are 
controlling systemic blood pressure and the subsequent rise in cerebral perfusion [1, 8]. 
Additional strategies to avoid cerebral hyperperfusion include staged angioplasty, which is 
conventional angioplasty in the first session followed by CAS in the second session [18, 23]. 
In our series, one patient who underwent staged angioplasty did not develop HPP after CAS, 
and this case was not included in the analyses. Other reported stepwise revascularizations 
were superficial temporal artery-MCA anastomosis followed by CEA and angioplasty 
followed by CEA, and there was no evidence that these methods prevented cerebral 
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hyperperfusion [36, 37].   
Various cerebral perfusion tracers, including 123I-IMP, 99mTc-hexam-ethyl-propyleneamine 
oxime (HMPAO), and 99mTc-ethyl-cys-teinate dimer (ECD), have been used in the 
measurement of CBF by SPECT. These tracers necessitate underestimation of CBF in the 
high flow regions due to the nonlinear relationship between CBF and brain uptake of these 
tracers [38]. Among these tracers, IMP was reported to have a closer linear relationship than 
HMPAO and ECD; thus, we selected IMP for measurement of CBF [38,39]. 
  This study has some limitations. First, it was a retrospective analysis with a small sample 
size. The number of female patients in this study was low (11/84); although, female sex was a 
significant factor of HPP by univariate logistic analysis. Second, this study evaluated the 
occurrence of HPP, and the results cannot be applied to the occurrence of symptomatic HPP 
(HPS) or intracranial hemorrhage following CAS. Finally, the ROI method was evaluated in 
only a single slice, and our study does not include analysis of the basal ganglia. 
 
Conclusion 
SPECT using the SEE method can analyze brain perfusion data objectively and reproducibly, 
in contrast with the ROI method. Logistic regression analysis demonstrated that reduced 
preoperative CVR was significantly associated with the development of cerebral HPP 
following CAS. The present study shows that the objective evaluation of cerebral 
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hemodynamic impairment using the SEE analysis could identify patients at risk for 
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A: Representative case with the development of cerebral hyperperfusion. Preoperative 
cerebral blood flow (CBF) at rest (left) and after the administration of acetazolamide 
(ACZ; middle) showed a marked decrease in CBF in the left middle cerebral artery 
(MCA) area after ACZ. Asymptomatic cerebral hyperperfusion occurred the day after 
carotid artery stenting (right). 
B: The stereotactic extraction estimation (SEE) method demonstrated CBF of the anterior 
cerebral artery (ACA), MCA, and posterior cerebral artery (PCA) at rest and after 
acetazolamide. The SEE analyses also automatically calculated the cerebrovascular 
reactivity (CVR) of each region. The border zone of ACA, MCA, and PCA, which was 
automatically set by these analyses, is shown on the brain surface image (arrows).   
C: Perfusion analyses using the region of interest (ROI) method of a representative case is 
shown. The ACA, anterior and posterior part of the MCA, anterior and posterior part of 
white matter (WM), and PCA were placed on the slice at the anterior 
commissure-posterior commissure level +20 mm. CBF at rest and after ACZ, asymmetry 




 Receiver-operating characteristic curve of the cerebrovascular reactivity (CVR) of the 
middle cerebral artery area using the stereotactic extraction estimation (SEE) method for 
prediction of the cerebral hyperperfusion phenomenon (HPP) after carotid artery stenting. 
The area under the curve was 0.981, and a cutoff value of -0.60% for the prediction of 




Table 1. Univariate analysis of clinical characteristics related to the development of 
cerebral hyperperfusion after carotid artery stenting 
  Cerebral Hyperperfusion   
Variables Yes (n = 10) No (n = 74) P Value 
Age, y 73.1±6.3 69.8±7.2 0.109 
Female 5 (50%) 6 (8%) 0.003 
Symptomatic lesion 8 (80%) 51 (69%) 0.716 
Degree of stenosis, % 86.1±9.4 72.7±18.1 0.026 
Contralateral stenosis 5 (50%) 11 (15%) 0.019 
Risk factors       
  Hypertension 10 (100%) 51 (69%) 0.055 
  Diabetes mellitus 3 (30%) 35 (48%) 0.500 
  Dyslipidemia 5 (50%) 30 (41%) 0.735 
  Renal insufficiency 3 (30%) 23 (31%) 1.000 
  Current smoking 2 (20%) 17 (23%) 1.000 
Medication       
  Aspirin 10 (100%) 74 (100%) 1.000 
  Clopidogrel 10 (100%) 69 (93%) 0.698 
  Cilostazol 3 (30%) 22 (30%) 1.000 
  Statin 9 (90%) 52 (71%) 0.272 
CAS procedure       
  Balloon protection 2 (20%) 15 (21%) 1.000 
  Predilatation 10 (100%) 67 (91%) 0.591 
  Open-cell stent 5 (50%) 35 (47%) 1.000 
  Postdilatation 7 (70%) 63 (85%) 0.359 
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Peak systolic velocity, cm/s       
  Pre-CAS 392±252 424±181 0.475  
  Post-CAS 139±92 113±47 0.239  







Table 2. Univariate analysis of cerebral perfusion analyses using the stereotactic extraction estimation 
method related to the development of cerebral hyperperfusion after carotid artery stenting  










CBF at rest, ml/100 
g/min 
33.3 ± 4.2 35.9 ± 7.5 0.607  0.446 - 0.768 0.275 
  
CBF after ACZ, 
ml/100 g/min 
30.9 ± 5.5 44.1 ± 10.7 0.901  0.823 - 0.979 <0.001 
  
Asymmetry index at 
rest 
0.93 ± 0.08 0.98 ± 0.05 0.703  0.496 - 0.910 0.038 
  CVR, % -7.1 ± 12.8 22.7 ± 14.3 0.970  0.937 - 1.000 <0.001 
MCA 
CBF at rest, 
ml/100g/min 
32.0 ± 4.3 35.0 ± 7.2 0.641  0.484 - 0.798 0.149 
  
CBF after ACZ, 
ml/100 g/min 
26.9 ± 6.0 43.1 ± 9.7 0.926  0.862- 0.989 <0.001 
  
Asymmetry index at 
rest 
0.85 ± 0.09 0.97 ± 0.09 0.804  0.658 - 0.950 0.002 
  CVR, % -15.9 ± 14.0 23.5 ± 17.1 0.981  0.956 - 1.000 <0.001 
PCA 
CBF at rest, ml/100 
g/min 
36.2 ± 6.8 37.4 ± 7.0 0.572  0.393 - 0.751 0.460 
  
CBF after ACZ, 
ml/100 g/min 
41.0 ± 13.9 50.0 ± 9.8 0.734  0.532 - 0.935 0.017 
  
Asymmetry index at 
rest 
0.91 ± 0.07 0.98 ± 0.05 0.800  0.665 - 0.935 0.002 
  CVR, % 13.2 ± 29.7 33.7 ± 15.2 0.714  0.498 - 0.929 0.029 
 ACZ: acetazolamide, AUC: area under the curve, CAS: carotid artery stenting, CBF: cerebral blood flow, CVR: 
cerebrovascular reactivity, SEE: stereotactic extraction estimation 
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Table 3. Univariate analysis of cerebral perfusion analyses using the region of interest method related to the 
development of cerebral hyperperfusion after carotid artery stenting  




Yes (n = 
10) 
No (n = 
74) 
AUC 95% confidence interval 
P 
Value 
ACA CBF at rest, ml/100 g/min 29.1 ± 4.4 32.2 ± 8.5 0.618  0.460 - 0.775 0.229 
  
CBF after ACZ,ml/100 
g/min 
26.4 ± 6.6 40.5 ±12.4 0.870  0.775 - 0.966 <0.001 
  Asymmetry index at rest 0.90 ± 0.13 0.99 ±0.13 0.746  0.589 - 0.903 0.012 
  CVR, % -9.3 ± 15.7 26.3 ±21.8 0.926  0.861 - 0.990 <0.001 
MCA anterior CBF at rest, ml/100 g/min 30.2 ± 4.1 33.5 ± 8.3 0.635  0.480 - 0.790 0.167 
  
CBF after ACZ,ml/100 
g/min 
24.6 ± 5.2 41.7 ±12.7 0.923  0.863 - 0.983 <0.001 
  Asymmetry index at rest 0.87 ± 0.16 0.98 ±0.28 0.655  0.437 - 0.874 0.112 
  CVR, % -18.4 ±12.7 24.5 ±21.5 0.973  0.941 - 1.000 <0.001 
MCA posterior CBF at rest, ml/100 g/min 31.8 ± 6.1 34.9 ± 8.1 0.647  0.472 - 0.821 0.134 
  
CBF after ACZ,ml/100 
g/min 
24.9 ± 6.4 43.3 ±13.5 0.923  0.852 - 0.994 <0.001 
  Asymmetry index at rest 0.83 ± 0.08 0.97 ±0.09 0.868  0.723 - 1.000 <0.001 
  CVR, % -21.6 ±14.7 23.7 ±21.5 0.969  0.934 - 1.000 <0.001 
PCA CBF at rest, ml/100 g/min 37.6 ± 7.6 38.4 ± 8.9 0.528  0.346 - 0.711 0.772 
  
CBF after ACZ,ml/100 
g/min 
40.7 ± 16.9 50.6 ±12.6 0.743  0.554 - 0.933 0.013 
  Asymmetry index at rest 0.87 ± 0.08 0.97 ±0.10 0.776  0.652 - 0.900 0.005 
  CVR, % 7.4 ± 30.6 32.7 ±19.5 0.757  0.585 - 0.929 0.009 
WM anterior CBF at rest, ml/100 g/min 30.6 ± 3.7 33.4 ± 9.0 0.564  0.411 - 0.718 0.512 
  
CBF after ACZ,ml/100 
g/min 
22.8 ± 4.8 39.6 ±12.1 0.935  0.881 - 0.989 <0.001 
  Asymmetry index at rest 0.84 ± 0.11 0.97 ±0.16 0.797  0.659 - 0.935 0.002 
  CVR, % -25.3 ±13.3 18.8 ±21.7 0.961  0.920 - 1.000 <0.001 
WM posterior CBF at rest, ml/100 g/min 32.1 ± 4.6 34.6 ± 8.4 0.599  0.435 - 0.764 0.310 
  
CBF after ACZ,ml/100 
g/min 
21.8 ± 6.6 39.3 ±11.8 0.916  0.842 - 0.990 <0.001 
  Asymmetry index at rest 0.86 ± 0.11 0.98 ±0.10 0.846  0.675 - 1.000 <0.001 





ACZ: acetazolamide, AUC: area under the curve, CAS: carotid artery stenting, CBF: cerebral blood flow, CVR: 
cerebrovascular reactivity, ROI: region of interest, WM: white matter 
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Table 4. Multivariate logistic regression analysis results 
  Odds ratio (95% confidence interval) 
P 
value 
Female 829.973  ( 0.502  － 1371393.865  ) NS 
Contralateral stenosis 134.642  ( 0.435  － 41647.018  ) NS 
Degree of stenosis 0.917  ( 0.740  － 1.136  ) NS 
CVR 0.720  ( 0.526  － 0.987  ) 0.041 
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